At Winship, Phase I clinical trials are critical to advancing cancer care. These studies validate the best way to administer a new treatment and the best dose.
Each study answers scientific questions focused on finding better methods to prevent, screen, diagnose or treat cancer. Medications used as standard of care today, such as pembrolizumab, nivolumab, belantamab mafodotin, selpercatinib and many others, were all first evaluated in phase I clinical trials.
Our Phase I Unit at Winship enrolls patients into clinical trials for a variety of different cancer types. Learn about eligibility by searching trials now available.
The current unit is designed to be both patient-focused and able to support the painstaking demands of rigorous clinical research. It features 15 private treatment bays, four clinic rooms, plus many key support resources, including a dedicated lab for processing patient blood work, a dedicated secure medication room and a "fast track" bay with three chairs for rapid use by patients who might only require a short visit such as a research lab draw. The design of the space was guided by a multi-disciplinary team of patients, nurses, physicians, and research staff.
The Phase I Unit is a resource for the entire state and represents a strengthening of our commitment to patients throughout Georgia by developing options for advanced treatment.
Since 2009, we have annually enrolled 200+ patients on our trials, and we reflect the population we serve. Our program offers trials throughout a variety of cancer types, with representation from each specific group. As examples, 20% or more of patients enrolled are African-American, and 30% have multiple myeloma.
Our goals are to open trials quickly to offer novel treatments to patients, advance the science and technology developed at Emory, and conduct trials in a safe, welcoming environment.
Your Treatment Team
- Physician Diagnosticians
- Nurse Navigators
- Adv Practice
- Support Services
- Clinical Trials
- Dr. Bhave is passionate about women’s health and is a board certified medical oncologist specializing in the treatment of patients with breast cancer.
- Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
- (404) 778-1900
- Dr. Cohen's clinical focus is on the treatment of Hodgkin and non-Hodgkin lymphoma, where he manages both newly diagnosed patients as well as those requiring stem cell transplantation and treatment for relapsed disease.
- Co-Director, Lymphoma Program, Winship Cancer Institute of Emory University
- (404) 778-0519
- Dr. Hofmeister's practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance.
- Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
- (404) 778-0519
- Internationally recognized as a leading authority in multiple myeloma treatment and research, Dr. Lonial collaborates with leadership as Chief Medical Officer to coordinate and enhance clinical services and patient care throughout Winship.
- Chief Medical Officer, Winship Cancer Institute of Emory University
- (404) 778-0519